Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
| ▸ | MIF | P14174 | 1/20 | 0.33 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16363528 | 1.00 | TP53 (0.38) | TP53CYP3A4TDP1KCNN4CES2 | |
| SCHEMBL775291 | 1.00 | TP53 (0.38) | TP53CYP3A4TDP1KCNN4CES2 | |
| SCHEMBL19199344 | 0.81 | SLC6A4 (0.41) | TP53KCNN4LMNA | |
| SCHEMBL29182302 | 0.80 | TP53 (0.40) | TP53CYP3A4TDP1KCNN4CES2 | |
| SCHEMBL776216 | 0.80 | TP53 (0.40) | TP53CYP3A4TDP1KCNN4CES2 | |
| SCHEMBL30828031 | 0.80 | TP53 (0.40) | TP53CYP3A4TDP1KCNN4CES2 | |
| SCHEMBL1314975 | 0.78 | CYP3A4 (0.38) | CYP3A4TDP1CES2CES1 | |
| SCHEMBL20921242 | 0.78 | CYP3A4 (0.38) | CYP3A4TDP1CES2CES1 | |
| SCHEMBL6913189 | 0.78 | CYP3A4 (0.38) | CYP3A4TDP1CES2CES1 | |
| SCHEMBL12283711 | 0.77 | ACHE (0.40) | CYP3A4TDP1ACHEELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8367871-B2 | Process for production of optically active sulfoxide compound using iron-salan complex catalyst | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-20100094037-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE SULFOXIDE COMPOUND USING IRON-SALAN COMPLEX CATALYST | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094037-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE SULFOXIDE COMPOUND USING IRON-SALAN COMPLEX CATALYST | SCLY, SFXN1, SQOR | TP53 4860/4885CYP3A4 316/4885TDP1 4854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.